UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~October~~November 2023

Commission File Number: 001-39633

Abcam plc

(Translation of registrant’s name into English)

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

OnAs ~~October~~previously disclosed in the Report of Foreign Private Issuer on Form 6-K filed on August 2328, 2023, by Abcam plc (the “Company”), ~~issued~~on aAugust 26, ~~press~~2023 ~~release (~~the ~~“Announcement”)~~Company ~~announcing~~entered ~~that~~into ~~leading independent~~an ~~proxy~~agreement ~~advisor,~~with ~~Glass~~Danaher ~~Lewis,~~Corporation ~~had~~(“Danaher”) ~~recommended~~and ~~that~~Diadem ~~the~~Holdco ~~Company’s~~Limited ~~shareholders~~(the ~~vote~~“Purchaser”), inproviding ~~favor~~for, ofsubject ~~Danaher~~to ~~Corporation’s~~the ~~proposed~~terms and ~~acquisition~~conditions of ~~the~~such ~~Company~~transaction agreement (the “~~Acquisition~~Transaction Agreement”), ~~and~~the ~~sent~~acquisition ~~soliciting~~of ~~materials~~the Company by the Purchaser (the “~~Materials~~Acquisition”), towhich ~~its~~is ~~shareholders~~expected ~~relating~~ to ~~the~~be ~~Acquisition.~~implemented Aby ~~copy~~means of ~~the~~a ~~Announcement~~scheme ~~and~~of arrangement under the ~~Materials~~laws ~~are~~of ~~furnished~~England ~~herewith~~and ~~as Exhibits 99~~Wales.1, ~~and~~As ~~99.2,~~previously ~~respectively,~~disclosed toin ~~this~~the Report of Foreign Private Issuer on Form 6-K, filed on October 5, 2023, the Company announced the publication of a scheme circular, together with the related forms of proxy, in connection with the court meeting of the Company’s shareholders (the “Court Meeting”) and general meeting of the Company’s shareholders (the “General Meeting”) required to implement the Acquisition.

~~ADDITIONAL~~The ~~INFORMATION~~Company ~~AND~~today ~~WHERE~~issued TOa ~~FIND~~press ITrelease announcing that the resolutions put to the Company’s shareholders at the Court Meeting and the General Meeting, which were each held on November 6, 2023, were passed by the requisite majority of votes. A copy of the press release is furnished as Exhibit 99.1 hereto.

This Report of Foreign Private Issuer on Form 6-K is being made in respect of the Acquisition. The Company has mailed or otherwise provided to its shareholders the scheme circular in connection with the Acquisition (the “Scheme Circular”) containing information on the Scheme vote.

This communication is not a substitute for the Scheme Circular or any other document that may be filed or furnished by the Company with the SEC. Investors and security holders are urged to carefully read the entire Scheme Circular (which will include an explanatory statement in respect of the Scheme in accordance with the requirements of the U.K. Companies Act 2006) and other relevant documents as and when they become available because they will contain important information. You may obtain copies of all documents filed with or furnished to the SEC regarding this transaction, free of charge, at the SEC’s website (www.sec.gov).

In addition, investors and shareholders will be able to obtain free copies of the Scheme Circular and other documents filed with or furnished to the SEC by the Company on its Investors website (https://corporate.abcam.com/investors/danaher-abcam) or by writing to the Company, at 152 Grove Street, Building 1100 Waltham, MA 02453, United States of America.

EXHIBIT INDEX

Exhibit No.		Description
99.1		Announcement dated ~~October~~November 236, 2023
99.2		Materials dated October 23, 2023

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	~~ABCAM PLC~~	ABCAM PLC
Date: October 23, 2023	By:	/s/ Alan Hirzel
Date: November 6, 2023		By:	/s/ Alan Hirzel
		~~Name:~~	~~Alan Hirzel~~Name:	Alan Hirzel
		~~Title:~~	~~Chief Executive Officer~~Title:	Chief Executive Officer

Filing Compare · Abcam plc